0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Choroidal Neovascularization - Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-216
Home | Market Reports | Health | Vision Care
Choroidal Neovascularization Epidemiology Forecast to 2028

Choroidal Neovascularization - Epidemiology Forecast to 2028

Code: DELV-Epid-216
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Choroidal Neovascularization - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Choroidal Neovascularization epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Choroidal Neovascularization Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Choroidal Neovascularization in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Choroidal Neovascularization outlook. It also includes the explanation of changing trends of epidemiology outlining the Choroidal Neovascularization scenario.

Choroidal Neovascularization Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Choroidal Neovascularization thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Choroidal Neovascularization explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Choroidal Neovascularization Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Choroidal Neovascularization

Key assessments
• Patient Segmentation in Choroidal Neovascularization
• Choroidal Neovascularization Risk & Burden
• Factors driving growth in a specific Choroidal Neovascularization patient population

1. Report Introduction
2. Choroidal Neovascularization Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Choroidal Neovascularization in 2016
2.2. Patient Share Distribution of Choroidal Neovascularization in 2028
3. Disease Background and Overview: Choroidal Neovascularization
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Choroidal Neovascularization in 7MM
4.3. Total Prevalent/ Incident Patient Population of Choroidal Neovascularization in 7MM – By Countries
5. Epidemiology of Choroidal Neovascularization by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.1.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.1.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.1.5. Diagnosed Cases of the Choroidal Neovascularization
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.4.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.4.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.4.5. Diagnosed Cases of the Choroidal Neovascularization
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.5.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.5.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.5.5. Diagnosed Cases of the Choroidal Neovascularization
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.6.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.6.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.6.5. Diagnosed Cases of the Choroidal Neovascularization
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.7.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.7.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.7.5. Diagnosed Cases of the Choroidal Neovascularization
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.8.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.8.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.8.5. Diagnosed Cases of the Choroidal Neovascularization
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Choroidal Neovascularization
5.9.3. Sub-Type Specific cases of the Choroidal Neovascularization *
5.9.4. Sex- Specific Cases of the Choroidal Neovascularization *
5.9.5. Diagnosed Cases of the Choroidal Neovascularization
6. Unmet Needs of the Choroidal Neovascularization
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

LIST OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Choroidal Neovascularization in 7MM
Table 2: Total Prevalent/Incident Cases of the Choroidal Neovascularization in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Choroidal Neovascularization in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Choroidal Neovascularization in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Choroidal Neovascularization in United States (2016-2028)*
Table 6: Diagnosed Cases of the Choroidal Neovascularization in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Choroidal Neovascularization in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Choroidal Neovascularization in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Choroidal Neovascularization in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Choroidal Neovascularization in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Choroidal Neovascularization in France (2016-2028)
Table 12: Sub-Type Specific cases of the Choroidal Neovascularization in France (2016-2028) *
Table 13: Sex- Specific Cases of the Choroidal Neovascularization in France (2016-2028) *
Table 14: Diagnosed Cases of the Choroidal Neovascularization in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Choroidal Neovascularization in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Choroidal Neovascularization in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Choroidal Neovascularization in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Choroidal Neovascularization in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Choroidal Neovascularization in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Choroidal Neovascularization in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Choroidal Neovascularization in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Choroidal Neovascularization in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Choroidal Neovascularization in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Choroidal Neovascularization in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Choroidal Neovascularization in UK (2016-2028) *
Table 26: Diagnosed Cases of the Choroidal Neovascularization in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Choroidal Neovascularization in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Choroidal Neovascularization in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Choroidal Neovascularization in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Choroidal Neovascularization in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Choroidal Neovascularization in 7MM
Figure 2: Total Prevalent/Incident Cases of the Choroidal Neovascularization in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Choroidal Neovascularization in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Choroidal Neovascularization in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Choroidal Neovascularization in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Choroidal Neovascularization in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Choroidal Neovascularization in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Choroidal Neovascularization in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Choroidal Neovascularization in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Choroidal Neovascularization in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Choroidal Neovascularization in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Choroidal Neovascularization in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Choroidal Neovascularization in France (2016-2028) *
Figure 14: Diagnosed Cases of the Choroidal Neovascularization in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Choroidal Neovascularization in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Choroidal Neovascularization in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Choroidal Neovascularization in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Choroidal Neovascularization in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Choroidal Neovascularization in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Choroidal Neovascularization in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Choroidal Neovascularization in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Choroidal Neovascularization in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Choroidal Neovascularization in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Choroidal Neovascularization in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Choroidal Neovascularization in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Choroidal Neovascularization in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Choroidal Neovascularization in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Choroidal Neovascularization in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Choroidal Neovascularization in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Choroidal Neovascularization in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

China Artificial Tears Market Report Forecast 2021 2027
China Artificial Tears Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-645
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China AR Lens Market Report Forecast 2021 2027
China AR Lens Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-1R5919
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and China Surgeon Gloves Market Insights Forecast to 2027
Global and China Surgeon Gloves Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-18J3285
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Cinema Lenses Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Cinema Lenses Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Amateur Users followed by Professional Users.Market Analysis and Insights Global Cinema Lenses MarketIn 2020 the global Cinema Lenses market size was US 5541 million and it is expected to reach US 7468.7 million by the end of 2027 with a CAGR of 4.7 during 20212027.Global Cinem.

120 Pages
Type: Report
Code: QYRE-Auto-23D24
Mon Sep 27 00:00:00 UTC 2021

Add to Cart